Nidal A. Qinna

1.6k total citations
79 papers, 1.2k citations indexed

About

Nidal A. Qinna is a scholar working on Molecular Biology, Pharmaceutical Science and Pharmacology. According to data from OpenAlex, Nidal A. Qinna has authored 79 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Pharmaceutical Science and 15 papers in Pharmacology. Recurrent topics in Nidal A. Qinna's work include Advanced Drug Delivery Systems (12 papers), Drug-Induced Hepatotoxicity and Protection (9 papers) and Drug Solubulity and Delivery Systems (7 papers). Nidal A. Qinna is often cited by papers focused on Advanced Drug Delivery Systems (12 papers), Drug-Induced Hepatotoxicity and Protection (9 papers) and Drug Solubulity and Delivery Systems (7 papers). Nidal A. Qinna collaborates with scholars based in Jordan, United Kingdom and Saudi Arabia. Nidal A. Qinna's co-authors include Adnan A. Badwan, Khalid Z. Matalka, Iyad Rashid, Amani Elsayed, Mayyas Al‐Remawi, Asim Farouk, A. M. Y. Jaber, Basel Arafat, Robert T. Forbes and Mohamed A. Alhnan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Molecules.

In The Last Decade

Nidal A. Qinna

75 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nidal A. Qinna Jordan 18 260 249 164 160 137 79 1.2k
Srikumar Chakravarthi Malaysia 23 315 1.2× 134 0.5× 86 0.5× 208 1.3× 120 0.9× 96 1.6k
Yanlong Hong China 22 376 1.4× 234 0.9× 282 1.7× 210 1.3× 67 0.5× 85 1.6k
Mehrnaz Mehrabani Iran 25 484 1.9× 114 0.5× 110 0.7× 159 1.0× 75 0.5× 84 1.6k
Mohamed El‐Sherbiny Egypt 27 677 2.6× 127 0.5× 135 0.8× 168 1.1× 172 1.3× 172 2.3k
Bushra Akhtar Pakistan 22 244 0.9× 91 0.4× 115 0.7× 90 0.6× 138 1.0× 78 1.2k
Filipa Mascarenhas‐Melo Portugal 21 211 0.8× 290 1.2× 248 1.5× 48 0.3× 200 1.5× 57 1.5k
Azim Akbarzadeh Iran 22 424 1.6× 133 0.5× 365 2.2× 107 0.7× 236 1.7× 78 1.5k
P. Rajaguru India 29 656 2.5× 110 0.4× 163 1.0× 103 0.6× 248 1.8× 57 2.2k
Euichaul Oh South Korea 21 274 1.1× 357 1.4× 159 1.0× 118 0.7× 55 0.4× 57 1.1k
Fei Wu China 24 424 1.6× 380 1.5× 260 1.6× 179 1.1× 39 0.3× 89 1.6k

Countries citing papers authored by Nidal A. Qinna

Since Specialization
Citations

This map shows the geographic impact of Nidal A. Qinna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nidal A. Qinna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nidal A. Qinna more than expected).

Fields of papers citing papers by Nidal A. Qinna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nidal A. Qinna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nidal A. Qinna. The network helps show where Nidal A. Qinna may publish in the future.

Co-authorship network of co-authors of Nidal A. Qinna

This figure shows the co-authorship network connecting the top 25 collaborators of Nidal A. Qinna. A scholar is included among the top collaborators of Nidal A. Qinna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nidal A. Qinna. Nidal A. Qinna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Ameer, Hamzeh J., Malek Zihlif, Wajdy Al‐Awaida, et al.. (2025). Targeting the proliferation of glioblastoma cells and enhancement of doxorubicin and temozolomide cytotoxicity through inhibition of PFKFB4 and HMOX1 genes with siRNAs. Scientific Reports. 15(1). 27861–27861. 3 indexed citations
2.
Al‐Samydai, Ali, et al.. (2024). Exploring the Phytoconstituents, Differential Pharmacology, and Interaction with Empagliflozin of Olea europaea Leaves Extracts. Indian Journal of Pharmaceutical Education and Research. 58(3s). s1008–s1017.
3.
Al‐Akayleh, Faisal, et al.. (2024). Chitosan/ Alginate/ Gelucire in-situ Gelling System for Oral Sustained Delivery of Paracetamol for Dysphagic Patients. Jordan Journal of Pharmaceutical Sciences. 17(2). 292–306. 1 indexed citations
4.
6.
Al‐Akayleh, Faisal, et al.. (2024). Dissecting the stability of Atezolizumab with renewable amino acid-based ionic liquids: Colloidal stability and anticancer activity under thermal stress. International Journal of Biological Macromolecules. 270(Pt 1). 132208–132208. 9 indexed citations
7.
Al‐Akayleh, Faisal, et al.. (2023). The Formulation and Evaluation of Deep Eutectic Vehicles for the Topical Delivery of Azelaic Acid for Acne Treatment. Molecules. 28(19). 6927–6927. 15 indexed citations
8.
Al‐Akayleh, Faisal, Jehad Nasereddin, Albert Bolhuis, et al.. (2023). Deep Eutectic Liquids as a Topical Vehicle for Tadalafil: Characterisation and Potential Wound Healing and Antimicrobial Activity. Molecules. 28(5). 2402–2402. 28 indexed citations
9.
Obeidat, Maher, et al.. (2023). Mellitin peptide quantification in seasonally collected crude bee venom and its anticancer effects on myelogenous K562 human leukaemia cell line. BMC Complementary Medicine and Therapies. 23(1). 132–132. 14 indexed citations
10.
El‐Elimat, Tamam, et al.. (2022). The effect of beetroot juice on airway inflammation in a murine model of asthma. Journal of Food Biochemistry. 46(12). e14381–e14381. 2 indexed citations
11.
Alzoughool, Foad, et al.. (2022). Impact of Sustained Exogenous Irisin Myokine Administration on Muscle and Myocyte Integrity in Sprague Dawley Rats. Metabolites. 12(10). 939–939. 3 indexed citations
12.
Khleifat, Khaled M., et al.. (2022). Protective Role of Combined Crataegus Aronia Ethanol Extract and Phytosomes Against Hyperglycemia and Hyperlipidemia in Streptozotocin-Induced Diabetic Rat. Biointerface Research in Applied Chemistry. 13(3). 207–207. 4 indexed citations
13.
Al‐Akayleh, Faisal, et al.. (2022). Chitosan-biotin topical film: preparation and evaluation of burn wound healing activity. Pharmaceutical Development and Technology. 27(4). 479–489. 10 indexed citations
14.
Hamdan, Imad I., et al.. (2021). Characterization of Insulin Mucoadhesive Buccal Films: Spectroscopic Analysis and In Vivo Evaluation. Symmetry. 13(1). 88–88. 9 indexed citations
15.
Dayyih, Wael Abu, et al.. (2015). Determination of Atorvastatin Pharmacokinetic Parameters by LC/MS-MS with Traditional Liquorice Beverage. 5(1). 17–24. 3 indexed citations
16.
Qinna, Nidal A.. (2013). Safety profile of suppository Hamamelis virginiana leaf extract. Journal of Medicinal Plants Research. 7(36). 2669–2679. 3 indexed citations
17.
Qinna, Nidal A., et al.. (2013). Evaluation of a functional food preparation based on chitosan as a meal replacement diet. Journal of Functional Foods. 5(3). 1125–1134. 18 indexed citations
18.
Mallah, Eyad, et al.. (2011). Plasma concentrations of 25-hydroxyvitamin D among Jordanians: Effect of biological and habitual factors on vitamin D status. BMC Clinical Pathology. 11(1). 8–8. 40 indexed citations
19.
Eftaiha, Ala’a F., Amani Elsayed, Mayyas Al‐Remawi, et al.. (2011). Factors Involved in Formulation of Oily Delivery System for Proteins Based on PEG-8 Caprylic/Capric Glycerides and Polyglyceryl-6 Dioleate in a Mixture of Oleic Acid with Chitosan. Journal of Dispersion Science and Technology. 32(5). 623–633. 10 indexed citations
20.
Qinna, Nidal A., Hashem A. Taha, Khalid Z. Matalka, & Adnan A. Badwan. (2009). A new herbal combination, Etana, for enhancing erectile function: an efficacy and safety study in animals. International Journal of Impotence Research. 21(5). 315–320. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026